Engflag

Strataderm

Quick links to important sections

Strataderm

Strataderm_DE

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Strataderm

Strataderm is a specialized topical medical device classified as a film-forming dressing, available in a transparent silicone gel formulation. Its function is physical, creating a continuous, flexible layer on the skin's surface, which distinguishes it from traditional pharmacological agents. It is manufactured by Stratpharma, a company specializing in advanced wound and scar care.

Quick Facts

Property Description
Active Ingredients Polydimethylsiloxanes (Dimethicone), Alkylmethyl Silicones
Form Transparent Gel (Silicone Gel Formulation)
Pharmacological Class Film-Forming Medical Device / Semi-Occlusive Dressing
Common Purpose Scar Management
Origin Synthetic (Polymerized Silicone Compounds)

What Type of Scar Management Product is Strataderm?

Strataderm is categorized by regulatory bodies as a Class I medical device for scar management, rather than a pharmaceutical drug. This classification confirms its identity as a high-level semi-occlusive dressing that delivers inert therapy via a silicone gel formulation. Silicone gel effectively reduces scar height, discoloration, and pain, and is utilized for its efficacy against both hypertrophic scars and keloids. This confirms that silicone therapy is widely accepted for improving the appearance and symptoms associated with abnormal scarring. The product is engineered to polymerize after application, transforming into a custom-fit, protective film. This form addresses the limitations of conventional silicone gel sheets by providing easier coverage for large, mobile, or contoured areas of the body, and is clinically recognized for its utility on joints and creases. Its topical route of administration ensures that its action is localized entirely at the scar surface without systemic absorption.

What is the Composition and General Purpose of Strataderm?

The product is an inert, synthetic combination product derived from medical silicone compounds, principally Polydimethylsiloxanes (Dimethicone) and Alkylmethyl Silicones, both types of Siloxanes. These active ingredients are non-volatile polymers designed to be non-reactive substances which form the essential protective barrier layer once the volatile carrier base evaporates. The formulation contains no alcohol, parabens, or fragrances, which makes it particularly suitable for patients with sensitive skin and for pediatric use.

The general purpose of Strataderm is to physically support the healing process by optimizing the scar microenvironment through hydration regulation. The deposited silicone gel formulation functions as a semi-occlusive barrier, which helps maintain the optimal moisture content by reducing Trans-Epidermal Water Loss (TEWL) from the scar tissue. Silicone products are considered a first-line, gold-standard non-invasive option for scar prophylaxis and therapy. Maintaining this essential balance supports the process of normalizing the collagen synthesis cycle, ultimately facilitating the softening and flattening of scar tissue.

Regulatory References

  1. first-line, gold-standard non-invasive option for scar prophylaxis

What side effects are possible with Strataderm?

Possible Side Effects and Safety Information

The safety profile of Strataderm is based on its regulatory classification as a Class I topical medical device, which is composed of inert silicone compounds that are not absorbed systemically. As a result, the official regulatory safety documentation does not list any serious or systemic adverse reactions.

Documented Localized Side Effects

The adverse events documented in safety materials are localized to the area of application. These reactions are typically a reason to discontinue use and include:

  • Irritation at the application site.
  • Redness or localized discolouration.
  • Pain or discomfort in the treated area.

No frequency classifications (such as common, rare, or very rare) are officially assigned to these effects in the regulatory documentation.

Population-Specific Safety Statements

Official safety materials explicitly address suitability for vulnerable groups, consistent with the product's inert composition:

  • Pediatrics and Infants: The product is stated as suitable for use on children and infants.
  • Sensitive Skin: It is affirmed as suitable for people with sensitive skin.
  • Pregnancy and Lactation: The product is stated as safe for use during pregnancy and whilst breastfeeding.

Safety Restrictions and Limitations

The safety profile is heavily defined by high-level restrictions on its use, which are strictly documented in the regulatory-equivalent materials:

  • Contraindicated Use: It must not be applied to open wounds or third-degree burns.
  • Application Sites: It must not be used in contact with mucous membranes or placed directly in the eyes.
  • Topical Co-administration: It should not be applied over other topical medications unless advised by a physician, due to the risk that the film may enhance the effect of the underlying drug.

Overdose and Emergency Response

The official regulatory profile for Strataderm, a non-systemic, film-forming silicone gel, defines its overdose context based on accidental ingestion rather than traditional pharmacological toxicity. Since the product's primary ingredients—Polydimethylsiloxanes and Alkylmethyl Silicones—are inert and non-absorbable, ingestion is not expected to cause systemic poisoning or classic drug overdose symptoms. The severity of the event relates primarily to physical exposure factors.

The documented overdose presentations focus on mechanical risks. Accidental swallowing may cause localized, self-limited discomfort in the mouth or throat, or temporary gastrointestinal upset. The most severe, officially recognized outcome is mechanical obstruction, which includes the potential for choking or foreign body complications such as intestinal blockage. This specific risk is noted as a particular consideration for the pediatric population.

Upon accidental ingestion, official regulatory statements mandate a clear emergency response: immediately contact a certified Poison Control Center for guidance. Immediate medical attention must be sought if swallowing the product results in a life-threatening mechanical complication, such as choking or difficulty breathing. Management is supportive and symptomatic, as the product's inert nature means a specific pharmacological antidote is neither required nor available.

Therapeutic Uses of Strataderm

What Strataderm Treats: Main Uses and Benefits

Easing Symptoms and Improving Scar Appearance

The product is commonly used in the symptomatic management of scars, including those prone to becoming hypertrophic or keloid. Topical silicone gel is considered relevant for supporting the healing process and assisting in the therapeutic management of scars resulting from burns, general surgical procedures, or trauma wounds. It is particularly used for managing symptoms related to scars that are raised, red, or symptomatic.

Strataderm is generally used to manage the development of new scars and may assist with the look of existing ones. It is commonly used to help soften the texture of raised, firm scar tissue, and contributes to easing the overall symptom load by reducing redness and discoloration, which supports a less noticeable appearance. It is also relevant for easing symptoms related to physical discomfort that may accompany the healing phase, such as persistent itching, tenderness, sensitivity, and the tight or pulling sensation. Applied to newly healed wounds, this use supports the patient during the healing phase.

Quick Fact: Supports Easing Physical Discomfort The product is applied when appropriate for managing symptoms that create noticeable physiological strain, which includes sensations of itching and skin tightness associated with scar tissue.

Eligibility and Restrictions for Use

Who Can and Cannot Use Strataderm

The eligibility profile for Strataderm, a topical silicone film-forming dressing, is defined by its non-systemic action. Official regulatory information focuses on application site conditions and broad population suitability, rather than systemic health status.

Eligibility Scope

Category Official Regulatory Statement
Populations Allowed Suitable for all age groups, including infants and children (Use is explicitly permitted).
Pregnancy & Lactation Confirmed as safe to use during both pregnancy and breastfeeding.
Systemic Conditions None specified in official labeling regarding hepatic, renal, or cardiovascular impairment.

Absolute Exclusions and Restrictions

Use is restricted based on the application site and skin condition. The product must not be applied to specific local conditions as detailed in the official labeling:

  • Open Wounds: Must not be applied directly to open wounds or in the presence of exudate.
  • Burns: Must not be applied on third-degree burns.
  • Anatomical Sites: Application is prohibited near mucous membranes or the eyes.
  • Concurrent Use: Must not be applied over other topical medications or skin treatments unless advised by a physician, defining a conditional restriction.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Strataderm is determined by its classification as a topical medical device (silicone gel formulation) and the inert, non-systemic nature of its ingredients. Regulatory documentation confirms that this product has no documented systemic pharmacokinetic or pharmacodynamic interactions with other prescription or non-prescription medicines.

Absence of Systemic Drug Interactions

Interaction Type Official Regulatory Status
Pharmacokinetic Interactions (CYP enzymes, Transporters) None documented.
Pharmacodynamic Interactions (Additive Effects) None documented.
Interactions with Ingested Substances (Food, Alcohol, Supplements) None documented.

Administration-Order Constraint

Because the product functions by forming a protective physical barrier (a silicone film) on the skin's surface, the only interaction-related constraint is a mandatory administration-order rule regarding other topical preparations. The product must not be applied over any other creams, lotions, ointments, or moisturizers. Official labeling states that to ensure the proper formation and adherence of the silicone film, the application site must be completely clean and dry before Strataderm is applied. The presence of other topical substances physically interferes with the product’s intended function, leading to a functional constraint rather than a pharmacological interaction.

Mechanism of Action

Biophysical Mechanism and Hydration Feedback

The mechanism of action is biophysical, stemming from the application of combined Polydimethylsiloxanes and Alkylmethyl Silicones to the skin surface. These inert polymers polymerize to form a specialized, semi-occlusive film that adheres directly to the stratum corneum. This physical barrier is the core mechanistic component, reducing Trans-Epidermal Water Loss (TEWL) and increasing tissue hydration. This enhanced hydration acts as a critical biophysical signal, modulating the local physical environment of the scar.

Modulating Fibroblast Activity and Collagen Remodeling

The altered hydration signal attenuates stress-induced signaling within keratinocytes, which reduces the release of pro-inflammatory factors and exaggerated growth signals, such as Transforming Growth Factor beta (TGF-beta), directed toward dermal fibroblasts. This indirect modulation influences the collagen synthesis cycle by shifting the ratio of collagen formation to degradation. The physiological consequence of this long-term biophysical input is the influence on the alignment and structuring of the tissue components.

Dosage and Administration Information

How Strataderm is Used: Official Administration Guidelines

Strataderm is a specialized topical medical device (film-forming dressing) utilized for scar management, and its administration is guided by specific official use protocols. As a Class I medical device, its principles of use are distinct from pharmaceutical drugs, focusing on the maintenance of a continuous physical barrier.

Administration Scope

Entity Application Instructions
Route of administration Topical (external application only).
Dosing schedule Apply a very thin layer; the dose is defined by the amount that dries within 3–4 minutes.
Preparation requirements The application site must be clean and dry. Use begins after the wound is fully closed and sutures are removed.
Age-group rules Approved for use in children and infants. Also suitable for use during pregnancy and whilst breastfeeding.

Instruction Classifications (High-Level)

Classification Description
Administration method type Topical
Frequency pattern Daily (once daily, or twice daily for exposed areas).
Use-context constraints A minimum treatment duration of 60–90 days (2–3 months) is required.

Resulting Procedural Structure

The official usage protocol requires the scar area to be clean and dry prior to applying the thin layer of gel. The gel does not need to be rubbed in, as its function is non-penetrating and relies on forming a protective surface film. The key principle of the administration is to maintain continuous contact with the skin 24 hours a day, 7 days a week, for the specified duration. Once the gel has dried completely, the film may be covered by sun screen, cosmetics, or pressure garments as part of daily routines. This defined protocol ensures the correct physical application of the device for its intended purpose.

Recent Clinical Evidence

Strataderm: Recent Clinical Evidence

Strataderm is a silicone-based preparation utilized in the management of scars. Clinical research focuses on its use in improving the appearance of scars resulting from surgical procedures, trauma, chronic wounds, burns, and other skin injuries.

Summary of Mechanism and Application

The formulation contains silicone, which is hypothesized to influence scar formation by creating an occlusive barrier over the skin. This barrier is thought to assist in regulating moisture and temperature exchange at the scar site, thereby helping to normalize the production of collagen. Studies suggest that this approach may help soften and flatten raised scars, while potentially reducing associated redness and itching.

Key Research Findings

A systematic review and several comparative studies have investigated the outcomes associated with topical silicone preparations, including Strataderm. The evidence supports its use in the non-invasive management of both hypertrophic scars and keloids.

Scar Outcome Measure Typical Study Finding
Scar Height Observed reductions in elevation and hardness
Color (Erythema) Reported lightening of pigmentation
Flexibility/Softness Noted improvements in scar pliability

Research has indicated that adherence to the recommended duration of use is associated with more noticeable changes in scar appearance. Furthermore, tolerability data from clinical application generally reported a low incidence of adverse reactions, primarily limited to mild, transient local irritation.

Frequently Asked Questions (FAQ)

Common questions about Strataderm (FAQ)

Q: Is Strataderm used for new scars or old scars?

According to the official product information, Strataderm is intended for the treatment of both old and new scars. It is also used for the prevention of abnormal scar formation, such as hypertrophic scars and keloids, following wound closure.

Q: How many days does it take to see results?

Official information indicates that the recommended minimum treatment duration is between 60 to 90 days (2 to 3 months). Larger and older scars may require treatment for a longer period. Continued use is indicated until no further improvement in the scar's appearance is observed, consistent with the product's official instructions.

Q: How does Strataderm compare to silicone sheets?

Strataderm is a self-drying silicone gel that forms a flexible 'sheet' or film on the skin. Clinical information notes that the gel form can facilitate easier coverage and maintenance of constant contact on exposed areas, joints, and irregular surfaces, which addresses limitations often associated with conventional silicone sheets.

Q: What happens if I stop using Strataderm for a few days?

Official material indicates the product is intended to maintain continuous contact with the scar 24 hours a day, 7 days a week, throughout the recommended treatment period. Maintaining this constant seal is key to how the product works to manage the scar microenvironment.

Q: How do I know if the layer I applied is thin enough?

Official directions provide a clear way to verify the correct amount. When applied correctly, a very thin layer of the gel should dry within 3 to 4 minutes. If the application takes longer than this to dry completely, it suggests too much gel has been applied, and the official instructions state that any excess should be gently removed with a tissue.

Q: Can I use Strataderm on my face?

Official product information indicates that the gel is suitable for application to all areas of the skin, including exposed areas like the face and neck. However, the product must not be used on or near mucous membranes or placed directly into the eyes.

Q: How long does one tube of Strataderm last?

The duration of use depends on the size of the tube and the size of the scar being treated. For example, official product information indicates that a 5g tube is sufficient to treat a small, linear scar (2–3 cm) for over 90 days. A larger 50g tube can treat a much wider area (6x12 cm) for the same 90-day minimum duration.

Q: What are the key differences between Strataderm and Stratamed?

According to the manufacturer's product distinction, Strataderm is a silicone gel specifically for treating scars once the wound is fully closed and healed. Stratamed is intended as a film-forming wound dressing that, according to its labeling, may be applied immediately to compromised skin and open wounds before the scar is fully formed.

How should Strataderm be stored and disposed of?

Strataderm gel is a topical medical device with specific handling and disposal requirements detailed in its official labeling.

Official Storage and Stability

Requirement Classification/Condition
Container Integrity The tube must be reclosed tightly with the cap after each use and must not be used if damaged.
Child Protection The product must be stored out of the reach of children.
Stability Do not use after the expiration (EXP) date printed on the tube; this date remains unchanged once the tube has been opened.

Regulatory information does not specify a temperature range or require protection from light or moisture beyond ensuring the cap is tightly closed.

Official Disposal Rules

No special disposal methods are required for Strataderm. Unused or expired product should be disposed of by following local disposal regulations. The product is not classified as hazardous waste, and disposal should align with standard household guidelines for non-hazardous medical materials.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Strataderm found in:

A-Z Index: